# Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

> **NCT01134042** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 587 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone Furoate/Vilanterol Inhalation Powder
- **DRUG:** Fluticasone Furoate Inhalation Powder
- **DRUG:** Fluticasone Propionate Inhalation Powder
- **OTHER:** Placebo Inhalation Powder 1
- **OTHER:** Placebo Inhalation Powder 2

## Key facts

- **NCT ID:** NCT01134042
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 587 (ACTUAL)
- **Last updated:** 2017-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01134042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01134042, "Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01134042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*